Diclofenac Sodium – Prolonged‑Release (PR) Formulation
Diclofenac sodium is a non‑steroidal anti‑inflammatory drug (NSAID) that reduces pain, swelling, and fever by inhibiting cyclo‑oxygenase (COX) enzymes. A “prolonged‑release” (PR) formulation is designed so that the drug is released more slowly into the body, giving a steadier blood level over 24 hours and usually requiring only one daily dose.
---
1. What is the PR form of diclofenac sodium?
| Feature | Conventional (IR) | Prolonged‑Release (PR) |
|--------|--------------------|------------------------|
| Typical dose | 50–75 mg every 6–8 h (max 150 mg/day) | 75–100 mg once daily (max 150 mg/day) |
| Duration of action | 4–6 h | 20–24 h |
| First‑dose effect | Rapid onset (15–30 min) | Slightly slower onset (30–60 min) |
| Side‑effect profile | GI upset can be dose‑related | GI side‑effects can be lower if taken with food; still risk of ulcers/bleeding |
| Convenience | Multiple daily doses | Once‑daily dosing; easier adherence |
---
2. How is it taken?
1. Take with food or milk – This helps protect the stomach lining and can reduce GI irritation.
2. Swallow whole – Do not crush, chew, or split tablets, because the coating is essential for the slow release.
3. Avoid alcohol – It can increase GI risk.
---
3. When is it used?
| Condition | Typical indication for PR diclofenac |
|----------|--------------------------------------|
| Osteoarthritis (OA) of the knee, hip, hand | Chronic pain & stiffness |
| Rheumatoid arthritis (RA) | Long‑term pain control |
| Ankylosing spondylitis | Daily maintenance |
| Low back pain (non‑acute) | Moderate‑severe pain |
| Post‑operative pain (in select cases) | For patients who need once‑daily dosing |
It is not indicated for acute, severe pain that requires a rapid onset of action (e.g., severe trauma). For those, an immediate‑release formulation is preferred.
---
4. Typical dosing
| Age group | Starting dose | Titration | Max daily dose |
|-----------|---------------|-----------|----------------|
| Adults | 75 mg once daily | Increase by 25 mg every 3–5 days if needed & tolerated | 150 mg/day |
| Elderly (≥65 yr) | 75 mg once daily (watch for renal/ GI tolerance) | Same titration | 150 mg/day |
Important: Always follow your prescriber’s instructions; never exceed the recommended dose.
---
5. Benefits of the PR formulation
| Benefit | Explanation |
|---------|-------------|
| Once‑daily dosing | Improves compliance, especially in patients who forget multiple doses. |
| Steady plasma level | May reduce peaks that are associated with GI irritation. |
| Reduced total daily dose (in some patients) | Some patients achieve adequate pain control at lower daily doses compared to IR formulations. |
| Lower incidence of breakthrough pain | Because drug levels stay above the effective threshold for longer. |
---
6. Risks & Side‑Effects
| Common | Less common | Rare but serious |
|--------|-------------|------------------|
| Upset stomach, heartburn, nausea | Diarrhea, constipation | GI bleeding, ulcers, perforation |
| Headache, dizziness | Rash, itching | Liver injury, renal impairment, hypersensitivity |
| Elevated blood pressure | Blood clots (DVT/PE) | Anaphylactic reactions, severe skin reactions |
Who should be cautious?
* Patients with a history of peptic ulcer disease, GI bleeding, or chronic constipation.
* Patients on anticoagulants or corticosteroids (increased bleeding risk).
* Renal or hepatic impairment (dose adjustment or alternative therapy).
* Elderly (higher risk for GI and renal side‑effects).
* Pregnancy/lactation – not recommended unless benefits outweigh risks.
---
7. Interactions
| Drug | Interaction | What to Watch For |
|------|-------------|-------------------|
| Warfarin / other anticoagulants | ↑ INR / bleeding | Monitor INR, consider dose adjustment |
| Other NSAIDs | Additive GI/renal risk | Avoid concurrent use unless monitored |
| ACE inhibitors / ARBs / diuretics | Renal impairment | Monitor renal function (CrCl) |
| SSRIs/SNRIs | ↑ GI bleeding | Watch for bleeding signs |
| Corticosteroids | ↑ GI bleeding, ulcers | Consider PPIs or H2 blockers |
Always disclose all medications—including OTC and herbal supplements—to your clinician.
---
8. What to do if you miss a dose
| Missed dose | Action |
|-------------|--------|
| < 3 h after scheduled time | Take as soon as remembered. |
| > 3 h after | Skip the missed dose; do not double the next dose. |
---
9. How long is it usually taken?
| Indication | Typical duration |
|------------|------------------|
| OA/RA | Weeks to months (often chronic) |
| Acute flare‑ups | 1–3 weeks (only if needed) |
| Post‑operative pain | 2–5 days (most often IR is preferred) |
Long‑term use increases risk of side‑effects; periodic assessment of efficacy and side‑effect profile is essential (e.g., every 3–6 months).
---
10. Alternatives if PR diclofenac is not suitable
| Alternative | Indication | Key Points |
|-------------|------------|------------|
| Celecoxib (COX‑2 selective) | OA/RA | Lower GI risk; monitor CV risk |
| Ibuprofen (IR) | Acute pain | Fast onset; multiple daily doses |
| Acetaminophen | Mild pain / fever | Safe for GI but no anti‑inflammatory effect |
| Topical diclofenac gel | Joint pain | Low systemic exposure |
---
11. Bottom line
* Prolonged‑release diclofenac sodium offers the convenience of once‑daily dosing while maintaining analgesic and anti‑inflammatory effects.
* It can be an excellent option for chronic pain management in OA, RA, and other musculoskeletal disorders, provided you have no contraindications (GI ulcers, significant renal/hepatic disease, high cardiovascular risk).
* Always use under a physician’s guidance, follow dosing instructions, and report any new symptoms (especially GI bleeding signs such as black/tarry stools, vomiting blood, or abdominal pain).
If you have any specific health concerns or questions about your own medication regimen, please consult your prescribing clinician or pharmacist for personalized advice.